awmsg logo



nepafenac (Nevanac®)


Reference No. 1509

Publication date:
16/08/2013


Last review date:
30/09/2016

Appraisal information

nepafenac (Nevanac®) 1 mg/ml eye drops


Company: Alcon Laboratories (UK) Ltd
BNF category: Eye
NMG meeting date: 19/06/2013
AWMSG meeting date: 17/07/2013
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: 1813
Ministerial ratification: 14/08/2013

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Nepafenac (Nevanac®) is recommended for use within NHS Wales for reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download